| Followers | 134 |
| Posts | 7040 |
| Boards Moderated | 0 |
| Alias Born | 02/09/2012 |
Sunday, November 17, 2013 10:59:40 AM
With all of your scenarios below...you are assuming Active Negative Decisions from the Govt. ..
The PRIMARY THREAT to XXII moving forward within a reasonable time in the U.S. is INACTION BY THE GOVT...and XXII would be between a ROCK AND A HARD PLACE to bring SUIT IN COURT to force a decision or action.
IMHO..the only truly promising hope for XXII moving forward with licensing, sales and distribution and therefore revenue is outside the U.S and with BT.
I Hold to my prediction...U.S Govt will be "passive-aggressive" and make "no decisions" that would promote any cigarette company's sales, regardless of whether they can be perceived as "less toxic" then what is in the market.
("The govt could reject our application for entry into the MSA but again that seems mighty unlikely since someone posted Goodrich passed the inspection by the TTB and our license was suppose to be forthcoming in 60-90 days.
Govt could reject the acquisition of NASCO but it was so small can't see why they would do that. Again, if this is done and the Goodrich application fails we would be locked out of the US market and I am not sure we could even produce cigarettes here strictly for export. Having both NASCO acquisition and Goodrich MSA application rejected seems extremely unlikely.
Govt could terminate the X22 trial but after 2 years of study I think they already know how that trial is going to turn out (out that should be completely in XXII's favor)." )
The PRIMARY THREAT to XXII moving forward within a reasonable time in the U.S. is INACTION BY THE GOVT...and XXII would be between a ROCK AND A HARD PLACE to bring SUIT IN COURT to force a decision or action.
IMHO..the only truly promising hope for XXII moving forward with licensing, sales and distribution and therefore revenue is outside the U.S and with BT.
I Hold to my prediction...U.S Govt will be "passive-aggressive" and make "no decisions" that would promote any cigarette company's sales, regardless of whether they can be perceived as "less toxic" then what is in the market.
("The govt could reject our application for entry into the MSA but again that seems mighty unlikely since someone posted Goodrich passed the inspection by the TTB and our license was suppose to be forthcoming in 60-90 days.
Govt could reject the acquisition of NASCO but it was so small can't see why they would do that. Again, if this is done and the Goodrich application fails we would be locked out of the US market and I am not sure we could even produce cigarettes here strictly for export. Having both NASCO acquisition and Goodrich MSA application rejected seems extremely unlikely.
Govt could terminate the X22 trial but after 2 years of study I think they already know how that trial is going to turn out (out that should be completely in XXII's favor)." )
Recent XXII News
- 22nd Century Group (Nasdaq: XXII) Launches Pinnacle VLN® Trial in California, Opening Another Major New State for Reduced-Nicotine Cigarettes • GlobeNewswire Inc. • 05/21/2026 11:00:00 AM
- 22nd Century Group (Nasdaq: XXII) Expands High-Margin Pinnacle Platform With Launch of Pinnacle Pure at Major U.S. Retailers • GlobeNewswire Inc. • 05/18/2026 01:00:00 PM
- 22nd Century Group (Nasdaq: XXII) Ignites Major VLN® Retail Expansion in Metro New York and Northern New Jersey Under Pinnacle Brand • GlobeNewswire Inc. • 05/15/2026 12:37:00 PM
- 22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review • GlobeNewswire Inc. • 05/12/2026 05:50:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 10:30:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 10:06:10 AM
- 22nd Century Group Reports First Quarter 2026 Financial Results • GlobeNewswire Inc. • 05/07/2026 10:00:00 AM
- 22nd Century Group to Announce First Quarter 2026 Results on May 7, 2026 • GlobeNewswire Inc. • 05/04/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 09:20:20 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/01/2026 09:15:15 PM
- 22nd Century Group Shares 2026 Vision for VLN® Product Growth and Tobacco Harm Reduction Leadership • GlobeNewswire Inc. • 04/29/2026 08:35:00 PM
- 22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University • GlobeNewswire Inc. • 04/23/2026 11:50:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/13/2026 04:15:24 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/10/2026 08:35:13 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/10/2026 08:30:36 PM
- 22nd Century Advances Reduced Nicotine Product to Target Approximately Half of the ~$82 Billion U.S. Cigarette Market with 100mm VLN® Product Initiative • GlobeNewswire Inc. • 04/07/2026 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/31/2026 09:00:54 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/27/2026 08:30:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 12:02:51 PM
- 22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/26/2026 10:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/24/2026 05:57:09 PM
- 22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026 • GlobeNewswire Inc. • 03/23/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 09:14:20 PM
- 22nd Century Group Reports Continued Early Sales Momentum for VLN® Cigarette Products • GlobeNewswire Inc. • 02/23/2026 10:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 09:15:28 PM
